TRDA: Entrada Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 416.77
Enterprise Value ($M) 349.17
Book Value ($M) 242.36
Book Value / Share 7.50
Price / Book 1.72
NCAV ($M) 142.94
NCAV / Share 4.42
Price / NCAV 2.92

Profitability (mra)
Return on Invested Capital (ROIC) -0.02
Return on Assets (ROA) -0.01
Return on Equity (ROE) -0.03

Liquidity (mrq)
Quick Ratio 2.33
Current Ratio 2.33

Balance Sheet (mrq) ($M)
Current Assets 369.77
Assets 469.19
Liabilities 226.83
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 129.01
Operating Income -3.16
Net Income -6.68
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 139.80
Cash from Investing -138.40
Cash from Financing 21.04

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Price T Rowe Associates Inc /md/ 9.00 -0.16
02-14 13G/A Roche Finance Ltd 8.20 -2.47
02-14 13G/A Redmile Group, LLC 3.80 -30.76

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-08 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2023-08-08 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-16 8,382 44,344 18.90
2024-04-15 19,219 21,014 91.46
2024-04-12 6,908 22,214 31.10
2024-04-11 17,450 33,449 52.17

(click for more detail)

Similar Companies
TKNO – Alpha Teknova, Inc. TLPH – Talphera, Inc.
TNGX – Tango Therapeutics, Inc. TRVI – Trevi Therapeutics, Inc.
TSBX – Turnstone Biologics Corp.


Financial data and stock pages provided by
Fintel.io